Emmaus Life Sciences, Inc.
EMMA
$0.01
$0.00-1.02%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -213.63% | 48.03% | 46.41% | -244.58% | 2,626.87% |
| Total Depreciation and Amortization | 200.00% | -33.33% | -16.67% | -16.67% | -37.50% |
| Total Amortization of Deferred Charges | 105.80% | 85.51% | -79.96% | -89.43% | -88.16% |
| Total Other Non-Cash Items | 141.60% | -133.16% | 437.50% | 58.31% | -8.89% |
| Change in Net Operating Assets | 736.81% | 53.80% | -41.95% | 237.89% | -84.54% |
| Cash from Operations | 176.35% | 0.31% | 99.29% | -66.89% | 155.17% |
| Capital Expenditure | -100.00% | 66.67% | -- | 0.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -13.40% | -- | -- | 100.00% |
| Cash from Investing | -100.00% | -13.33% | -- | 66.67% | 100.25% |
| Total Debt Issued | 65.50% | 103.00% | -13.86% | -55.48% | -81.19% |
| Total Debt Repaid | -87.88% | -128.20% | 34.14% | 46.07% | 67.07% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -128.77% | 20.85% | 63.87% | -3,800.00% | -188.66% |
| Foreign Exchange rate Adjustments | -94.74% | 150.00% | 162.50% | -170.59% | 311.11% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -119.26% | -139.57% | 93.29% | -87.14% | -287.50% |